I mistakenly posted the response below to a psea post

New Post Public Reply Private Reply Replies (0) Message Board
ClosetInvestor misiu143 #26406
480
I mistakenly posted the response below to a psea post earlier this morning. I’m not sure how that happened, but the message was meant for misiu143, a response to her post #26406 from her yesterday. My apologies psea.

“It look that some group of people absolutely can’t accept that this treatment (hydroxychloroquine) is working with many, especially when started soon...”

You’re a self proclaimed doctor, who has also claimed to have participated in administering clinical trial medications to patients, and you’re asking why investors and health care professionals wont accept a clinically unproven drug for COVID? That’s absurd. You, of anyone, should understand how the FDA works in regards to approving drugs for certain indications. Yes, doctors talk amongst themselves and share preliminary results, but that talk is not meant for the general population and isn’t considered FACTs until proven by an official study. Dr. Fauci, the CDC, and the FDA are treating hydroxychloroquine like every other potential COVID treatment until a study shows efficacy: an unproven drug for the indication. And, of any drug for COVID patients, hydroxychloroquine needs further research because of the trials from China and around the world that have shown very different results.

“We all know why I believe ...”

I’m not sure what answer is possible because you personally aren’t prescribing the medication to COVID patIents and there isn’t an FDA approved trial showing efficacy. There is only anecdotal data that varies widely in efficacy.

Media and social media platforms are dangerous with disinformation in regards to COVID19 and treatments. I came across a video from a “Dr.” yesterday on social media that was discussing preventions and treatment for COVID19. This video had over 100K views. The “Dr.” was discussing notes he’d gotten from another Dr at an urgent care that showed promising results with early anti-biotic treatment. This “Dr.” then started discussing alternative treatments and prevention, including drinking tonic water everyday to prevent one from contracting COVID. After a little research, I discovered this “Dr.” is actually a chiropractor and is the owner of a wellness center. He didn’t mention this In the video, but from the comments, people were widely supporting his unsupported claims.

This is dangerous and people on social media are making similar videos and claims about hydroxychloroquine. I want to keep this non-political and consider myself in the middle on politics (more apolitical than anything), but I’d like to point out that the majority of individuals really pushing hydroxychloroquine are conservative and have ZERO medical knowledge. Like why’s, those who really bash the medication tend to be liberals. The topic of hydroxychloroquine and COVID should’ve never become political and should’ve been left to doctors and researchers, but unfortunately like every aspect of life today, politicians politicize everything for personal and political gain.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas Power Expands with Boyland Electric Acquisition

Updated Category News Views 92

The Strategy Behind Atlas Power's Expansion Atlas Power Partners, no stranger to sizzling ambitions, has galvanized its portfolio by roping in Boyland Electric. This latest maneuver unfolds as Atlas hustles to become the go-to network for residential generator services. It’s a clear bet on 'quality over flair'—an ethos echoed by their CEO, David Fischer, who champions...

Continue Reading
Academy Sports Teams Up With Little Debbie for Holidays

Updated Category News Views 22

Collaboration Brews Between Academy and Little Debbie Holiday cheer isn't complete without a mash-up that gets tongues wagging and wallets opening. Only this time, a sporting goods giant and your favorite snack cake brand are bringing us the yuletide spirit. Academy Sports + Outdoors has teamed up with Little Debbie for a limited-time collaboration under its Magellan...

Continue Reading
Ebix and intentyx Tackle AI Security in Regulated Fields

Updated Category News Views 138

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Continue Reading
Monetary Metals' Bold $38M Gold Bond: A Strategic Leap

Updated Category News Views 129

A Golden Opportunity in Uncertain Times Monetary Metals just pulled a rabbit outta the hat with this $38 million gold bond. That’s tripling the size from their 2024 offering. Normally, I'm skeptical about flashy bond numbers, but there's a glint of genius here. In a world teetering on the brink of financial chaos, investors are itching for something solid. And gold?...

Continue Reading
Dark Horse Cranes Secures Major Contracts in Texas

Updated Category News Views 52

Dark Horse Cranes: A Rising Player in Texas Midland, Texas just got hotter, and it’s got nothing to do with the sun. Dark Horse Cranes LLC is ramping up operations across the Permian Basin and digital infrastructure markets, marking its debut with a hefty $5.6 million in contract awards. Not too shabby for just 90 days since launch. These contracts throw five of their...

Continue Reading
Neros & the $615M Push: America’s Drone Ambitions

Updated Category News Views 57

Unveiling America's Drone Manufacturing Surge Straight talk, folks—there's a roaring play on the horizon with drones, and Neros is right at the spearhead. A fresh $450 million conditional loan from the Office of Strategic Capital (OSC) is lighting up the field, and if you're not paying attention, you're already falling behind. Add $165 million more in cold hard Neros...

Continue Reading
Multi-mind Mayhem: Anime Debut Shakes Things Up

Updated Category News Views 43

Anime on the Horizon: What's the Buzz? Ever thought about living in a world where one body can carry three entirely different minds? Well, that's precisely what the TV anime Multi-mind Mayhem is all set to bring to the table. Announced by YTE LTD., this intriguing series will hit the screens in January 2027. Fans have been given a sneak peek with the first key visual and...

Continue Reading
YeePay's B2B Payment Innovations Target Airlines' Pain Points

Updated Category News Views 157

A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...

Continue Reading
Wet Noses Innovates Human-Grade Pet Food at PLMA 2026

Updated Category News Views 83

Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...

Continue Reading
Virginia Innovation Boosts Startups and Research Growth

Updated Category News Views 95

Virginia's Rising Innovation Ecosystem Virginia, a place you might not expect to hear much about in terms of innovation, is actually shaking things up and making waves on a national scale. Throwing their hat into the innovation arena, Virginia's landed itself a cozy #5 spot for its 'Innovation and Research Ecosystem,' according to Area Development's latest rankings. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Impact of Job Reports on Market Volatility

Updated Category News Views 182

Understanding Market Dynamics Before Job Reports Recently, we witnessed a significant decline in rates, driven by an ISM services report that fell short of expectations. This has prompted discussions among market analysts about potential implications for various sectors and economic indicators. As a result, the 10-year Treasury bond yield experienced a dip to the 4.4%...

Continue Reading
Revenue Management Labs Expands PE Pricing Focus

Updated Category News Views 8

Digging Deeper into Private Equity’s Untapped Asset: Pricing Roll up those sleeves because Revenue Management Labs just rolled into New York, ready to stir the pot for private equity with a fresh take on pricing strategies. This ain’t your grandma’s pricing strategy; we’re talking AI-driven precision that sings across the mid-market and large-cap arenas. Based on...

Continue Reading
Bharat Electronics' Future Looks Bright Despite Recent Fluctuations

Updated Category News Views 365

Bharat Electronics' Investment Potential Assessment In recent evaluations by CLSA, Bharat Electronics Ltd (BHE:IN) has been recognized for its strong investment potential, despite a slight correction in stock value. The firm continues to uphold an Outperform rating for the company, reflecting confidence in its future prospects. With a price target set at INR294.00, CLSA's...

Continue Reading
Sharon AI Collaborates with Industry Leaders for Advanced Video Solutions

Updated Category News Views 486

Sharon AI Teams Up with Top Tech Companies Sharon AI, Inc., a vibrant force in high-performance computing and artificial intelligence, has recently taken a significant step forward by teaming up with several leading companies in the tech sector. This collaboration includes Next DC, Layercake, Grass Valley, and AI-MEDIA, with the aim of transforming cloud-based media...

Continue Reading
Market Trends and Future of Machine Tools Industry

Updated Category News Views 327

Overview of the Machine Tools Market Growth The machine tools market is on an impressive trajectory, with projections indicating it will soar from an estimated USD 106.55 billion in 2023 to USD 189.44 billion by 2032. This remarkable growth is expected to manifest at a compound annual growth rate (CAGR) of 6.65% from 2024 to 2032. The key factors contributing to this boom...

Continue Reading